Hydroxychloroquine-induced Stevens–Johnson syndrome in COVID-19: a rare case report
Open Access
- 1 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2020 (6) , 193-195
Abstract
The international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19) began in December 2019 that has affected >0.8 million individuals. Self-limiting respiratory tract involvement, severe pneumonia, multiorgan failure and death are the spectrum of COVID-19. To date, there are no especial therapeutic agents for COVID-19 infections. One such medication includes the antimalarial hydroxychloroquine (HCQ), which recently reported as a possible therapy for shortening the duration of COVID-19 symptoms, reducing inflammatory reactions to infection, impairing the exacerbation of pneumonia and boosting lung imaging findings. Like all medications, HCQ has side effects and may occur in COVID-19 patients. Here, we report on the case of a 42-year-old woman, presented with fever and dry cough, who had COVID-19 and 2 days later presented with a pruritic erythematous maculopapular rash, which started from the distal of upper extremities and rapidly, involved the entire body.Keywords
All Related Versions
This publication has 9 references indexed in Scilit:
- Chloroquine and hydroxychloroquine in covid-19BMJ, 2020
- Cutaneous manifestations in COVID‐19: a first perspectiveJournal of the European Academy of Dermatology and Venereology, 2020
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progressionJournal of Antimicrobial Chemotherapy, 2020
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatologyNature Reviews Rheumatology, 2020
- Appreciation Professor Johan W. Mouton, 3 November 1956–9 July 2019Journal of Antimicrobial Chemotherapy, 2019
- Targeting inflammation with collagen-binding antibodiesNature Reviews Rheumatology, 2019
- Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysisClinical and Experimental Dermatology, 2008
- Hydroxychloroquine-induced DRESS syndromeClinical Rheumatology, 2007
- Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritisRheumatology, 2002